Terms: = Prostate cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
7 results:
1. prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early treatment in prostate cancer Patients Managed with Active Surveillance.
Ahmadi E; Wang S; Gouran-Savadkoohi M; Douvi G; Isfahanian N; Tsakiridis N; Faught BE; Cutz JC; Sur M; Chawla S; Pond GR; Steinberg GR; Brown I; Tsakiridis T
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003213
[TBL] [Abstract] [Full Text] [Related]
2. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract] [Full Text] [Related]
3. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
4. axin2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
Hu BR; Fairey AS; Madhav A; Yang D; Li M; Groshen S; Stephens C; Kim PH; Virk N; Wang L; Martin SE; Erho N; Davicioni E; Jenkins RB; Den RB; Xu T; Xu Y; Gill IS; Quinn DI; Goldkorn A
Prostate; 2016 May; 76(6):597-608. PubMed ID: 26771938
[TBL] [Abstract] [Full Text] [Related]
5. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant prostate cancer.
Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
[TBL] [Abstract] [Full Text] [Related]
6. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract] [Full Text] [Related]
7. Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells.
Gwak J; Lee JH; Chung YH; Song GY; Oh S
PLoS One; 2012; 7(10):e46697. PubMed ID: 23071615
[TBL] [Abstract] [Full Text] [Related]
